Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Jing Luo, Assistant Professor of Medicine, University of Pittsburgh Health Sciences

Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes

High insulin prices are leaving some people who need the drug without access. Erik McGregor/LightRocket via Getty Images

Doctors have been treating diabetes with insulin since 1922. A century later, about 1 in 5 of the 37 million Americans living with diabetes take this medication – a hormone that helps cells absorb sugar from the blood.

This medication helps avert a host of medical problems including heart disease, kidney disease and stroke. Some 1.6 million Americans living with Type 1 diabetes, a condition in which people don’t produce any insulin, depend on it for their survival. So do millions more people with Type 2 diabetes – a condition in which the body doesn’t make enough insulin.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.